Jessica Chang, MA
Articles
May 22nd 2023
Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim
Jessica Chang, MA Pinar Karaca-Mandic, PhD Ronald S. Go, MD Stephen Schondelmeyer, PharmD, PhD Daniel Weisdorf, MD Molly Moore Jeffery, PhD, MPP
Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.
August 23rd 2021
Site of Care Potentially Limits Cost Savings From Biosimilars
Jessica Chang, MA Pinar Karaca-Mandic, PhD Ronald S. Go, MD Stephen Schondelmeyer, PharmD, PhD Daniel Weisdorf, MD Molly Moore Jeffery, PhD, MPP
Although previous work has found lower costs for biosimilar filgrastim compared with reference filgrastim, this study found that site of care can change this calculus, reducing savings.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
